NCT00074802View on ClinicalTrials.gov

Adding Cognitive Behavioral Therapy to Drug Treatment for Social Anxiety Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
Social Anxiety Disorder
Interventions
DRUG

Paroxetine

Treatment with paroxetine will consist of an immediate release, flexible dosage of 20 to 50 mg per day.

BEHAVIORAL

Cognitive behavioral therapy (CBT)

CBT will consist of 16 weekly treatment sessions.

Trial Locations (2)

10032

New York State Psychiatric Institute Anxiety Disorders Clinic, New York

19122-6085

Adult Anxiety Clinic of Temple University, Philadelphia

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Temple University

OTHER

NCT00074802 - Adding Cognitive Behavioral Therapy to Drug Treatment for Social Anxiety Disorder | Biotech Hunter | Biotech Hunter